Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

VENCLEXTA®

A to Z: Drugs in Highlight: V is for VENCLEXTA®

News A to Z Feature 30/04/2025

Our A to Z series highlights VENCLEXTA® (venetoclax) from AbbVie, a medication used to treat both chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML). This article explores its mechanism of action, clinical applications, and the patent protection surrounding this important drug.

Read more
AI
Industry news, News 02/01/2025

UK Government Proposes New Copyright Rules for AI Development

Secerna Website Images 2023 (65)
News 20/12/2024

Seasons Greetings from Secerna

UK Expands Trade Mark Options Partial Replacement Now Possible (2)
Industry news, News 19/12/2024

UKIPO Expands Trade Mark Options with changes to Replacement Legislation

Erivedge
News, Team news, A to Z Feature 19/12/2024

A to Z: Drugs in Highlight: E is for ERIVEDGE

D Is For DURYSTA
News, A to Z Feature 12/12/2024

A to Z: Drugs in Highlight: D is for DURYSTA

Rebranding
Industry news, News 09/12/2024

Safeguarding Innovation: IP Considerations in Rebranding

CERDELGA
News, A to Z Feature 04/12/2024

A to Z: Drugs in Highlight: C is for CERDELGA

Secerna Website Images 2023 (63)
European, Industry news, News 03/12/2024

Extension of the European Patent Office’s Patent Prosecution Highway Programme

A To Z Drugs In Highlight B Is For BREO ELLIPTA
Industry news, News, A to Z Feature 28/11/2024

A to Z: Drugs in Highlight: B is for BREO ELLIPTA

1 2 3 4 5 6 7 8 9 10 11